OxFORD Asset Management LLP cut its holdings in shares of Halyard Health, Inc. (NYSE:HYH) by 16.0% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 55,414 shares of the medical instruments supplier’s stock after selling 10,573 shares during the quarter. OxFORD Asset Management LLP owned approximately 0.12% of Halyard Health worth $2,177,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. State Board of Administration of Florida Retirement System increased its holdings in Halyard Health by 11.2% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 32,077 shares of the medical instruments supplier’s stock worth $1,222,000 after acquiring an additional 3,230 shares during the last quarter. Comerica Bank increased its holdings in Halyard Health by 4.3% in the 1st quarter. Comerica Bank now owns 37,158 shares of the medical instruments supplier’s stock worth $1,464,000 after acquiring an additional 1,535 shares during the last quarter. Swiss National Bank increased its holdings in Halyard Health by 1.2% in the 1st quarter. Swiss National Bank now owns 76,900 shares of the medical instruments supplier’s stock worth $2,929,000 after acquiring an additional 900 shares during the last quarter. UBS Asset Management Americas Inc. increased its holdings in Halyard Health by 11.3% in the 1st quarter. UBS Asset Management Americas Inc. now owns 34,269 shares of the medical instruments supplier’s stock worth $1,305,000 after acquiring an additional 3,473 shares during the last quarter. Finally, Karp Capital Management Corp purchased a new stake in Halyard Health in the 1st quarter worth about $1,069,000. 91.02% of the stock is owned by hedge funds and other institutional investors.

Several brokerages recently weighed in on HYH. Zacks Investment Research raised Halyard Health from a “hold” rating to a “buy” rating and set a $44.00 price objective for the company in a report on Wednesday, July 12th. Stifel Nicolaus reissued a “buy” rating and issued a $45.00 price objective on shares of Halyard Health in a report on Thursday, September 21st. Stephens raised Halyard Health from an “equal weight” rating to an “overweight” rating in a report on Thursday, August 3rd. Deutsche Bank AG lifted their price objective on Halyard Health from $35.00 to $42.00 and gave the stock a “buy” rating in a report on Thursday, August 3rd. Finally, BidaskClub raised Halyard Health from a “hold” rating to a “buy” rating in a report on Wednesday, June 28th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $42.25.

Shares of Halyard Health, Inc. (HYH) opened at 46.04 on Friday. The stock has a market cap of $2.15 billion, a price-to-earnings ratio of 44.27 and a beta of 1.75. The company has a 50-day moving average price of $45.16 and a 200 day moving average price of $40.28. Halyard Health, Inc. has a one year low of $31.59 and a one year high of $46.63.

Halyard Health (NYSE:HYH) last posted its earnings results on Wednesday, August 2nd. The medical instruments supplier reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.14. Halyard Health had a return on equity of 8.29% and a net margin of 3.06%. The company had revenue of $399.20 million for the quarter, compared to the consensus estimate of $399.16 million. During the same quarter in the prior year, the company earned $0.45 earnings per share. Halyard Health’s revenue was down .2% on a year-over-year basis. Equities research analysts expect that Halyard Health, Inc. will post $1.96 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This news story was posted by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be read at https://www.watchlistnews.com/halyard-health-inc-hyh-shares-sold-by-oxford-asset-management-llp/1615011.html.

Halyard Health Company Profile

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Want to see what other hedge funds are holding HYH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Halyard Health, Inc. (NYSE:HYH).

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.